Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator
Authors:
- Benico BarzilaiBBBenico Barzilai
- Fernando GutierrezFGFernando Gutierrez
- Allan S. JaffeAJAllan S. Jaffe
- Paul EisenbergPEPaul Eisenberg
- 1 October 1990
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 120 (4) , 978-980
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group.Circulation, 1989
- Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system.Circulation, 1988
- Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activatorEuropean Heart Journal, 1987
- Ultrasonic assessment of the St. Jude prosthetic valve: M mode, two-dimensional, and Doppler echocardiography.Circulation, 1983